{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T07:51:33Z","timestamp":1778313093350,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260400"],"award-info":[{"award-number":["82260400"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515220005"],"award-info":[{"award-number":["2022A1515220005"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Shenzhen Science and Technology Program","award":["JCYJ20210324121613037"],"award-info":[{"award-number":["JCYJ20210324121613037"]}]},{"name":"The Shenzhen Key Medical Discipline Construction Fund","award":["SZXK054"],"award-info":[{"award-number":["SZXK054"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To establish and validate a droplet digital PCR (ddPCR) assay for quantifying FRS2 gene copy number in formalin-fixed paraffin-embedded (FFPE) bladder cancer tissue samples, and to evaluate its analytical performance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The ddPCR assay was developed using FRS2 as the target gene and RPP30 as the reference gene. Artificial plasmids, genomic DNA from urinary sediment of healthy individuals and cell lines were used as templates to assess the assay\u2019s precision, minimum reliable input DNA, and linearity. Fluorescence in situ hybridization (FISH) was employed to validate the accuracy of the ddPCR results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>One-dimensional fluorescence amplitude plots showed clear separation between positive and negative droplets for both FRS2 and RPP30. Duplex detection of FRS2 and RPP30 within the same reaction showed no interference between primers or probes. The assay exhibited excellent repeatability and precision, with intra-assay coefficient of variation (CV)% of 2.58% and 3.75%, and inter-assay CV% of 2.68% and 3.79%, across 20 ng and 2 ng input levels, respectively. The minimum reliable input DNA amount was determined to be 2 ng, and a strong linear relationship was observed (R<jats:sup>2<\/jats:sup> &gt;0.99). Compared to FISH, the ddPCR assay showed 100% sensitivity, 100% specificity, and a kappa value of 1.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The developed ddPCR assay enables accurate and reliable quantification of FRS2 copy number in FFPE samples, offering a promising tool for auxiliary diagnosis and prognostic assessment in bladder cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12885-025-14611-0","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T14:18:47Z","timestamp":1753366727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Droplet digital PCR assay for precise determination of FRS2 gene copy number in bladder cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Jinqian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanzheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"14611_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1233","volume":"8","author":"M Mojarrad","year":"2020","unstructured":"Mojarrad M, Moghbeli M. Genetic and molecular biology of bladder cancer among Iranian patients. Mol Genet Genomic Med. 2020;8: e1233.","journal-title":"Mol Genet Genomic Med"},{"key":"14611_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"14611_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41585-019-0208-0","volume":"16","author":"C Alifrangis","year":"2019","unstructured":"Alifrangis C, McGovern U, Freeman A, Powles T, Linch M. Molecular and histopathology directed therapy for advanced bladder cancer. Nat Rev Urol. 2019;16:465\u201383.","journal-title":"Nat Rev Urol"},{"key":"14611_CR4","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"14611_CR5","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743.","journal-title":"BMJ"},{"key":"14611_CR6","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ng.2798","volume":"45","author":"G Guo","year":"2013","unstructured":"Guo G, Sun X, Chen C, Wu S, Huang P, Li Z, et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet. 2013;45:1459\u201363.","journal-title":"Nat Genet"},{"key":"14611_CR7","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.1158\/1078-0432.CCR-12-1807","volume":"18","author":"CD Hurst","year":"2012","unstructured":"Hurst CD, Platt FM, Taylor CF, Knowles MA. Novel tumor subgroups of urothelial carcinoma of the bladder defined by integrated genomic analysis. Clin Cancer Res. 2012;18:5865\u201377.","journal-title":"Clin Cancer Res"},{"key":"14611_CR8","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1002\/ijc.32737","volume":"146","author":"G Sj\u00f6dahl","year":"2020","unstructured":"Sj\u00f6dahl G, Eriksson P, Patschan O, Marzouka NAD, Jakobsson L, Bernardo C, et al. Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma. Int J Cancer. 2020;146:2636\u201347.","journal-title":"Int J Cancer"},{"key":"14611_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3892\/etm.2021.10333","volume":"22","author":"V Spasova","year":"2021","unstructured":"Spasova V, Mladenov B, Rangelov S, Hammoudeh Z, Nesheva D, Serbezov D, et al. Clinical impact of copy number variation changes in bladder cancer samples. Exp Ther Med. 2021;22:901.","journal-title":"Exp Ther Med"},{"key":"14611_CR10","first-page":"1298","volume":"73","author":"K Zhang","year":"2013","unstructured":"Zhang K, Chu K, Wu X, Gao H, Wang J, Yuan YC, et al. Amplification of FRS2 and activation of FGFR\/FRS2 signaling pathway in high-grade liposarcoma. Cancer Res. 2013;73:1298\u2013307.","journal-title":"Cancer Res"},{"key":"14611_CR11","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1349-7006.2008.00840.x","volume":"99","author":"N Gotoh","year":"2008","unstructured":"Gotoh N. Regulation of growth factor signaling by FRS2 family docking\/scaffold adaptor proteins. Cancer Sci. 2008;99:1319\u201325.","journal-title":"Cancer Sci"},{"key":"14611_CR12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/PGP.0000000000000937","volume":"42","author":"S Niu","year":"2023","unstructured":"Niu S, Rivera-Colon G, Lucas E. Aggressive High-grade uterine sarcoma harboring MEIS1-NCOA2 fusion and amplification of multiple 12q13-15 genes: a case report with morphologic, immunohistochemical, and molecular analysis. Int J Gynecol Pathol. 2023;42:460\u20135.","journal-title":"Int J Gynecol Pathol"},{"key":"14611_CR13","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/his.13473","volume":"72","author":"W Jing","year":"2018","unstructured":"Jing W, Lan T, Chen H, Zhang Z, Chen M, Peng R, et al. Amplification of FRS2 in atypical lipomatous tumour\/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases. Histopathology. 2018;72:1145\u201355.","journal-title":"Histopathology"},{"key":"14611_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1158\/1541-7786.MCR-14-0407","volume":"13","author":"LY Luo","year":"2015","unstructured":"Luo LY, Kim E, Cheung HW, Weir BA, Dunn GP, Shen RR, et al. The tyrosine kinase adaptor protein FRS2 is oncogenic and amplified in high-grade serous ovarian cancer. Mol Cancer Res. 2015;13:502\u20139.","journal-title":"Mol Cancer Res"},{"key":"14611_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/gcc.22827","volume":"59","author":"L Amoroso","year":"2020","unstructured":"Amoroso L, Ognibene M, Morini M, Conte M, Di Cataldo A, Tondo A, et al. Genomic coamplification of CDK4\/MDM2\/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients. Genes Chromosomes Cancer. 2020;59:277\u201385.","journal-title":"Genes Chromosomes Cancer"},{"key":"14611_CR16","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/PAS.0000000000001125","volume":"42","author":"X He","year":"2018","unstructured":"He X, Pang Z, Zhang X, Lan T, Chen H, Chen M, et al. Consistent amplification of FRS2 and MDM2 in low-grade osteosarcoma: a genetic study of 22 cases with clinicopathologic analysis. Am J Surg Pathol. 2018;42:1143\u201355.","journal-title":"Am J Surg Pathol"},{"key":"14611_CR17","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1210\/jc.2013-2165","volume":"98","author":"MC De Martino","year":"2013","unstructured":"De Martino MC, Al Ghuzlan A, Aubert S, Assi\u00e9 G, Scoazec J-Y, Leboulleux S, et al. Molecular screening for a personalized treatment approach in advanced adrenocortical cancer. J Clin Endocrinol Metab. 2013;98:4080\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"14611_CR18","doi-asserted-by":"publisher","first-page":"e98293","DOI":"10.1371\/journal.pone.0098293","volume":"9","author":"Y Chen","year":"2014","unstructured":"Chen Y, McGee J, Chen X, Doman TN, Gong X, Zhang Y, et al. Identification of druggable cancer driver genes amplified across TCGA datasets. PLoS One. 2014;9:e98293.","journal-title":"PLoS One"},{"key":"14611_CR19","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41467-019-08576-5","volume":"10","author":"S Wu","year":"2019","unstructured":"Wu S, Ou T, Xing N, Lu J, Wan S, Wang C, et al. Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer. Nat Commun. 2019;10:720.","journal-title":"Nat Commun"},{"key":"14611_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1177\/2472630317705680","volume":"22","author":"AS Basu","year":"2017","unstructured":"Basu AS. Digital assays part I: partitioning statistics and digital PCR. SLAS Technol. 2017;22:369\u201386.","journal-title":"SLAS Technol"},{"key":"14611_CR21","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1021\/ac202578x","volume":"84","author":"LB Pinheiro","year":"2012","unstructured":"Pinheiro LB, Coleman VA, Hindson CM, Herrmann J, Hindson BJ, Bhat S, et al. Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification. Anal Chem. 2012;84:1003\u201311.","journal-title":"Anal Chem"},{"key":"14611_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2022.06.003","volume":"101","author":"AC M\u00fcller-Nedebock","year":"2022","unstructured":"M\u00fcller-Nedebock AC, Meldau S, Lombard C, Abrahams S, van der Westhuizen FH, Bardien S. Increased blood-derived mitochondrial DNA copy number in African ancestry individuals with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2022;101:1\u20135.","journal-title":"Parkinsonism Relat Disord"},{"key":"14611_CR23","doi-asserted-by":"publisher","first-page":"e1003363","DOI":"10.1371\/journal.pmed.1003363","volume":"17","author":"A Zivanovic Bujak","year":"2020","unstructured":"Zivanovic Bujak A, Weng C-F, Silva MJ, Yeung M, Lo L, Ftouni S, et al. Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: a cohort study. PLoS Med. 2020;17:e1003363.","journal-title":"PLoS Med"},{"key":"14611_CR24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/cid\/ciaa345","volume":"71","author":"F Yu","year":"2020","unstructured":"Yu F, Yan L, Wang N, Yang S, Wang L, Tang Y, et al. Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients. Clin Infect Dis. 2020;71:793\u20138.","journal-title":"Clin Infect Dis"},{"key":"14611_CR25","doi-asserted-by":"publisher","first-page":"e12445","DOI":"10.1111\/xen.12445","volume":"25","author":"U Fiebig","year":"2018","unstructured":"Fiebig U, Fischer K, B\u00e4hr A, Runge C, Schnieke A, Wolf E, et al. Porcine endogenous retroviruses: quantification of the copy number in cell lines, pig breeds, and organs. Xenotransplantation. 2018;25:e12445.","journal-title":"Xenotransplantation"},{"key":"14611_CR26","first-page":"7241","volume":"82","author":"E Mazaika","year":"2014","unstructured":"Mazaika E, Homsy J. Digital droplet PCR: CNV analysis and other applications. Curr Protoc Hum Genet. 2014;82:7241\u201372413.","journal-title":"Curr Protoc Hum Genet"},{"key":"14611_CR27","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1039\/D4LC00175C","volume":"24","author":"W Wei","year":"2024","unstructured":"Wei W, Li S, Zhang Y, Deng S, He Q, Zhao X, et al. Analytical validation of the DropXpert S6 system for diagnosis of chronic myelocytic leukemia. Lab Chip. 2024;24:3080\u201392.","journal-title":"Lab Chip"},{"key":"14611_CR28","doi-asserted-by":"publisher","first-page":"2365596","DOI":"10.1080\/16078454.2024.2365596","volume":"29","author":"Y Li","year":"2024","unstructured":"Li Y, Ye J, Liang L, Tan X, Zheng L, Qin T, et al. Detection of \u03b1-thalassemia South-east Asian deletion based on a fully integrated digital polymerase chain reaction system DropXpert S6. Hematology. 2024;29:2365596.","journal-title":"Hematology"},{"key":"14611_CR29","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s40291-021-00546-2","volume":"25","author":"T Wen","year":"2021","unstructured":"Wen T, Zhang X, Lippuner C, Schiff M, Stuber F. Development and evaluation of a droplet digital PCR assay for 8p23 \u03b2-defensin cluster copy number determination. Mol Diagn Ther. 2021;25:607\u201315.","journal-title":"Mol Diagn Ther"},{"key":"14611_CR30","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jcyt.2023.02.010","volume":"25","author":"J Ma","year":"2023","unstructured":"Ma J, Shao L, Fuksenko T, Liu H, Shi R, Dinh A, et al. Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays. Cytotherapy. 2023;25:598\u2013604.","journal-title":"Cytotherapy"},{"key":"14611_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/ng.3200","volume":"47","author":"RE Handsaker","year":"2015","unstructured":"Handsaker RE, Van Doren V, Berman JR, Genovese G, Kashin S, Boettger LM, et al. Large multiallelic copy number variations in humans. Nat Genet. 2015;47:296\u2013303.","journal-title":"Nat Genet"},{"key":"14611_CR32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1517\/14728220902942330","volume":"13","author":"T Sato","year":"2009","unstructured":"Sato T, Gotoh N. The FRS2 family of docking\/scaffolding adaptor proteins as therapeutic targets of cancer treatment. Expert Opin Ther Targets. 2009;13:689\u2013700.","journal-title":"Expert Opin Ther Targets"},{"key":"14611_CR33","doi-asserted-by":"publisher","first-page":"e0161274","DOI":"10.1371\/journal.pone.0161274","volume":"11","author":"CB Hughesman","year":"2016","unstructured":"Hughesman CB, Lu XJD, Liu KYP, Zhu Y, Poh CF, Haynes C. A robust protocol for using multiplexed droplet digital PCR to quantify somatic copy number alterations in clinical tissue specimens. PLoS One. 2016;11:e0161274.","journal-title":"PLoS One"},{"key":"14611_CR34","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.3390\/ijms22094732","volume":"22","author":"VY Cusenza","year":"2021","unstructured":"Cusenza VY, Bisagni A, Rinaldini M, Cattani C, Frazzi R. Copy number variation and rearrangements assessment in cancer: comparison of droplet digital PCR with the current approaches. Int J Mol Sci. 2021;22:4732.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"14611_CR35","doi-asserted-by":"publisher","first-page":"8604","DOI":"10.1021\/ac202028g","volume":"83","author":"BJ Hindson","year":"2011","unstructured":"Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, Makarewicz AJ, Bright IJ, Lucero MY, Hiddessen AL, Legler TC, et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem. 2011;83(22):8604\u201310.","journal-title":"Anal Chem"},{"key":"14611_CR36","doi-asserted-by":"crossref","unstructured":"Nadauld L, Regan JF, Miotke L, Pai RK, Longacre TA, Kwok SS, Saxonov S, Ford JM, Ji HP. Quantitative and sensitive detection of cancer genome amplifications from formalin fixed paraffin embedded tumors with droplet digital PCR. Transl Med (Sunnyvale). 2012;2(2):1000107.","DOI":"10.4172\/2161-1025.1000107"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14611-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14611-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14611-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T22:00:45Z","timestamp":1757282445000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14611-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14611"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14611-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Research Ethics Committee of Shenzhen Luohu People\u2019s Hospital. Written informed consent to participate was obtained from all participants. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1211"}}